Age VoicE, by Master of Information and Data Science alums Emma Choate, Vinith Kuruppu, and David Russell, aims to serve an ...

The new owners of US TikTok have an explanation for this weekend’s problems, and say they’re working to get things back online. The new owners of US TikTok have an explanation for this weekend’s ...

This project serves as a complete portfolio demonstrating my journey from Python fundamentals to advanced data analytics techniques. It includes hands-on examples of data cleaning, exploration, ...

President Trump promised to fill the appeals courts with “my judges.” They have formed a nearly united phalanx to defend his agenda from legal challenges. VOTES IN FAVOR OF TRUMP Trump appointees 92% ...

Unlock your potential as an automation artist! Learn how Ignition 8.3's new design features allow you to swiftly create stunning, custom SCADA screens, responsive forms and lightning-fast reports.

MILAN — The European Space Agency has confirmed a security breach of unclassified material from science servers following reports on social media. A threat actor claimed to have compromised ESA ...

The queue for power-intensive customers looking to tap into New York’s energy grid has surged as the boom for artificial intelligence and growth in large-scale manufacturing drive electricity demand, ...

Advanced data visualization and analytics have become central to enterprise IT strategies as organizations face rapid data growth from cloud services, software-as-a-service applications, edge devices, ...

To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Americans are hanging onto their smartphones for much longer than they did a decade ago, but new ...

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD. Return to part 1 of this interview, ...

Emma Walmsley and her GSK CEO successor, Luke Miels, are safeguarding the British pharma’s 40 billion-pound-sterling sales projection for 2031 on the back of a strong quarter. The GSK executives are ...